Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

10.1016/S1473-3099(21)00128-6

Saved in:
Bibliographic Details
Main Authors: Natasha Howard, Afolabi, MO, Ishola, D, Manno, D, Keshinro, B, Bockstal, V, Rogers, B, Owusu-Kyei, K, Serry-Bangura, A, Swaray, I, Lowe, B, Kowuor, D, Baiden, F, Mooney, T, Smout, E, Köhn, B, Otieno, GT, Jusu, M, Foster, J, Samai, M, Deen, GF, Larson, H, Lees, S, Goldstein, N, Gallagher, KE, Gaddah, A, Heerwegh, D, Callendret, B, Luhn, K, Robinson, C, Greenwood, B, Leyssen, M, Douoguih, M, Leigh, B, Watson-Jones, D, Kargbo, M, Bockarie, E, James, NL, Kabbah, A, Kamara, A, Koroma, KH, Langley, SO, William, N, Kessebeh, R, Conteh, L, Allieu, K, Bangura, K, Bangura, MS, Bangura, MA, Jalloh, H, Jalloh, AB, Kamara, I, Kamara, M, Konteh, A, Koroma, S, Marrah, C, Sesay, M, Sesay, MT, Deen, AT, Jalloh, A, Kaimbay, RM, Kain, D, Kamara, EL, Kamara, MP, Kamara, OJ, Kamara, SLM, Kanneh, M, Koroma, AH, Lahai, D, Mansaray, IS, Marah, WS, Massaquoi, MJ, Nabie, A, Saidu, NS, Samai, I, Tengheh, JN, Turay, AS, Fornah, A, Sesay, F, Sow, A, Swaray, E, Mansaray, F, Ade-Cole, T, Bangura, LM, Conteh, ML, Koroma, AM, Koroma, M, Sam, A, Scott, T, Sessie, T, Sunders, JHC, Turay, SIS, Weekes, J, Sheku, M, Gibson, L, Ahamed, I, Allieu, W, Kabba, DU
Other Authors: DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
Format: Article
Published: Elsevier BV 2023
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/243187
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-243187
record_format dspace
spelling sg-nus-scholar.10635-2431872024-11-11T04:20:30Z Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial Natasha Howard Afolabi, MO Ishola, D Manno, D Keshinro, B Bockstal, V Rogers, B Owusu-Kyei, K Serry-Bangura, A Swaray, I Lowe, B Kowuor, D Baiden, F Mooney, T Smout, E Köhn, B Otieno, GT Jusu, M Foster, J Samai, M Deen, GF Larson, H Lees, S Goldstein, N Gallagher, KE Gaddah, A Heerwegh, D Callendret, B Luhn, K Robinson, C Greenwood, B Leyssen, M Douoguih, M Leigh, B Watson-Jones, D Kargbo, M Bockarie, E James, NL Kabbah, A Kamara, A Koroma, KH Langley, SO William, N Kessebeh, R Conteh, L Allieu, K Bangura, K Bangura, MS Bangura, MA Jalloh, H Jalloh, AB Kamara, I Kamara, M Konteh, A Koroma, S Marrah, C Sesay, M Sesay, MT Deen, AT Jalloh, A Kaimbay, RM Kain, D Kamara, EL Kamara, MP Kamara, OJ Kamara, SLM Kanneh, M Koroma, AH Lahai, D Mansaray, IS Marah, WS Massaquoi, MJ Nabie, A Saidu, NS Samai, I Tengheh, JN Turay, AS Fornah, A Sesay, F Sow, A Swaray, E Mansaray, F Ade-Cole, T Bangura, LM Conteh, ML Koroma, AM Koroma, M Sam, A Scott, T Sessie, T Sunders, JHC Turay, SIS Weekes, J Sheku, M Gibson, L Ahamed, I Allieu, W Kabba, DU DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH) Assoc Prof Natasha Howard Adolescent Antibodies, Viral Child Child, Preschool Drug Administration Schedule Ebola Vaccines Ebolavirus Female Humans Immunogenicity, Vaccine Infant Injections, Intramuscular Male Sierra Leone Vaccines, DNA Viral Vaccines 10.1016/S1473-3099(21)00128-6 The Lancet Infectious Diseases 22 1 110-122 2023-07-18T07:53:17Z 2023-07-18T07:53:17Z 2022-01-01 2023-07-18T07:28:29Z Article Natasha Howard, Afolabi, MO, Ishola, D, Manno, D, Keshinro, B, Bockstal, V, Rogers, B, Owusu-Kyei, K, Serry-Bangura, A, Swaray, I, Lowe, B, Kowuor, D, Baiden, F, Mooney, T, Smout, E, Köhn, B, Otieno, GT, Jusu, M, Foster, J, Samai, M, Deen, GF, Larson, H, Lees, S, Goldstein, N, Gallagher, KE, Gaddah, A, Heerwegh, D, Callendret, B, Luhn, K, Robinson, C, Greenwood, B, Leyssen, M, Douoguih, M, Leigh, B, Watson-Jones, D, Kargbo, M, Bockarie, E, James, NL, Kabbah, A, Kamara, A, Koroma, KH, Langley, SO, William, N, Kessebeh, R, Conteh, L, Allieu, K, Bangura, K, Bangura, MS, Bangura, MA, Jalloh, H, Jalloh, AB, Kamara, I, Kamara, M, Konteh, A, Koroma, S, Marrah, C, Sesay, M, Sesay, MT, Deen, AT, Jalloh, A, Kaimbay, RM, Kain, D, Kamara, EL, Kamara, MP, Kamara, OJ, Kamara, SLM, Kanneh, M, Koroma, AH, Lahai, D, Mansaray, IS, Marah, WS, Massaquoi, MJ, Nabie, A, Saidu, NS, Samai, I, Tengheh, JN, Turay, AS, Fornah, A, Sesay, F, Sow, A, Swaray, E, Mansaray, F, Ade-Cole, T, Bangura, LM, Conteh, ML, Koroma, AM, Koroma, M, Sam, A, Scott, T, Sessie, T, Sunders, JHC, Turay, SIS, Weekes, J, Sheku, M, Gibson, L, Ahamed, I, Allieu, W, Kabba, DU (2022-01-01). Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial. The Lancet Infectious Diseases 22 (1) : 110-122. ScholarBank@NUS Repository. https://doi.org/10.1016/S1473-3099(21)00128-6 1473-3099 1474-4457 https://scholarbank.nus.edu.sg/handle/10635/243187 Elsevier BV Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Adolescent
Antibodies, Viral
Child
Child, Preschool
Drug Administration Schedule
Ebola Vaccines
Ebolavirus
Female
Humans
Immunogenicity, Vaccine
Infant
Injections, Intramuscular
Male
Sierra Leone
Vaccines, DNA
Viral Vaccines
spellingShingle Adolescent
Antibodies, Viral
Child
Child, Preschool
Drug Administration Schedule
Ebola Vaccines
Ebolavirus
Female
Humans
Immunogenicity, Vaccine
Infant
Injections, Intramuscular
Male
Sierra Leone
Vaccines, DNA
Viral Vaccines
Natasha Howard
Afolabi, MO
Ishola, D
Manno, D
Keshinro, B
Bockstal, V
Rogers, B
Owusu-Kyei, K
Serry-Bangura, A
Swaray, I
Lowe, B
Kowuor, D
Baiden, F
Mooney, T
Smout, E
Köhn, B
Otieno, GT
Jusu, M
Foster, J
Samai, M
Deen, GF
Larson, H
Lees, S
Goldstein, N
Gallagher, KE
Gaddah, A
Heerwegh, D
Callendret, B
Luhn, K
Robinson, C
Greenwood, B
Leyssen, M
Douoguih, M
Leigh, B
Watson-Jones, D
Kargbo, M
Bockarie, E
James, NL
Kabbah, A
Kamara, A
Koroma, KH
Langley, SO
William, N
Kessebeh, R
Conteh, L
Allieu, K
Bangura, K
Bangura, MS
Bangura, MA
Jalloh, H
Jalloh, AB
Kamara, I
Kamara, M
Konteh, A
Koroma, S
Marrah, C
Sesay, M
Sesay, MT
Deen, AT
Jalloh, A
Kaimbay, RM
Kain, D
Kamara, EL
Kamara, MP
Kamara, OJ
Kamara, SLM
Kanneh, M
Koroma, AH
Lahai, D
Mansaray, IS
Marah, WS
Massaquoi, MJ
Nabie, A
Saidu, NS
Samai, I
Tengheh, JN
Turay, AS
Fornah, A
Sesay, F
Sow, A
Swaray, E
Mansaray, F
Ade-Cole, T
Bangura, LM
Conteh, ML
Koroma, AM
Koroma, M
Sam, A
Scott, T
Sessie, T
Sunders, JHC
Turay, SIS
Weekes, J
Sheku, M
Gibson, L
Ahamed, I
Allieu, W
Kabba, DU
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
description 10.1016/S1473-3099(21)00128-6
author2 DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
author_facet DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
Natasha Howard
Afolabi, MO
Ishola, D
Manno, D
Keshinro, B
Bockstal, V
Rogers, B
Owusu-Kyei, K
Serry-Bangura, A
Swaray, I
Lowe, B
Kowuor, D
Baiden, F
Mooney, T
Smout, E
Köhn, B
Otieno, GT
Jusu, M
Foster, J
Samai, M
Deen, GF
Larson, H
Lees, S
Goldstein, N
Gallagher, KE
Gaddah, A
Heerwegh, D
Callendret, B
Luhn, K
Robinson, C
Greenwood, B
Leyssen, M
Douoguih, M
Leigh, B
Watson-Jones, D
Kargbo, M
Bockarie, E
James, NL
Kabbah, A
Kamara, A
Koroma, KH
Langley, SO
William, N
Kessebeh, R
Conteh, L
Allieu, K
Bangura, K
Bangura, MS
Bangura, MA
Jalloh, H
Jalloh, AB
Kamara, I
Kamara, M
Konteh, A
Koroma, S
Marrah, C
Sesay, M
Sesay, MT
Deen, AT
Jalloh, A
Kaimbay, RM
Kain, D
Kamara, EL
Kamara, MP
Kamara, OJ
Kamara, SLM
Kanneh, M
Koroma, AH
Lahai, D
Mansaray, IS
Marah, WS
Massaquoi, MJ
Nabie, A
Saidu, NS
Samai, I
Tengheh, JN
Turay, AS
Fornah, A
Sesay, F
Sow, A
Swaray, E
Mansaray, F
Ade-Cole, T
Bangura, LM
Conteh, ML
Koroma, AM
Koroma, M
Sam, A
Scott, T
Sessie, T
Sunders, JHC
Turay, SIS
Weekes, J
Sheku, M
Gibson, L
Ahamed, I
Allieu, W
Kabba, DU
format Article
author Natasha Howard
Afolabi, MO
Ishola, D
Manno, D
Keshinro, B
Bockstal, V
Rogers, B
Owusu-Kyei, K
Serry-Bangura, A
Swaray, I
Lowe, B
Kowuor, D
Baiden, F
Mooney, T
Smout, E
Köhn, B
Otieno, GT
Jusu, M
Foster, J
Samai, M
Deen, GF
Larson, H
Lees, S
Goldstein, N
Gallagher, KE
Gaddah, A
Heerwegh, D
Callendret, B
Luhn, K
Robinson, C
Greenwood, B
Leyssen, M
Douoguih, M
Leigh, B
Watson-Jones, D
Kargbo, M
Bockarie, E
James, NL
Kabbah, A
Kamara, A
Koroma, KH
Langley, SO
William, N
Kessebeh, R
Conteh, L
Allieu, K
Bangura, K
Bangura, MS
Bangura, MA
Jalloh, H
Jalloh, AB
Kamara, I
Kamara, M
Konteh, A
Koroma, S
Marrah, C
Sesay, M
Sesay, MT
Deen, AT
Jalloh, A
Kaimbay, RM
Kain, D
Kamara, EL
Kamara, MP
Kamara, OJ
Kamara, SLM
Kanneh, M
Koroma, AH
Lahai, D
Mansaray, IS
Marah, WS
Massaquoi, MJ
Nabie, A
Saidu, NS
Samai, I
Tengheh, JN
Turay, AS
Fornah, A
Sesay, F
Sow, A
Swaray, E
Mansaray, F
Ade-Cole, T
Bangura, LM
Conteh, ML
Koroma, AM
Koroma, M
Sam, A
Scott, T
Sessie, T
Sunders, JHC
Turay, SIS
Weekes, J
Sheku, M
Gibson, L
Ahamed, I
Allieu, W
Kabba, DU
author_sort Natasha Howard
title Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
title_short Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
title_full Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
title_fullStr Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
title_full_unstemmed Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
title_sort safety and immunogenicity of the two-dose heterologous ad26.zebov and mva-bn-filo ebola vaccine regimen in children in sierra leone: a randomised, double-blind, controlled trial
publisher Elsevier BV
publishDate 2023
url https://scholarbank.nus.edu.sg/handle/10635/243187
_version_ 1821212296982036480